• 2013

Company Description

Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.

Raze Therapeutics is leading the discovery and development of a new class of oncology therapeutics that target key metabolic pathways. Raze is advancing a pipeline of therapeutics based on new biological insights into how cancer cells reprogram metabolism to activate central anabolic processes essential for tumors to grow and survive.